Jan 30 (Reuters) - Merck (MRK.N), opens new tab plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in ...
Mr. Kennedy has referred clients to the firm in cases claiming injuries from the Gardasil vaccine, a Merck product that is meant to prevent cervical cancer that can be caused by the human ...
Merck must face trial on a Black IT director’s claims that racial bias drove his firing after he ordered the removal of a ...
Across the recent three months, 12 analysts have shared their insights on Merck & Co MRK, expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a ...
Citi lowered the firm’s price target on Merck (MRK) to $125 from $130 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the firm ...
Wisner Baum is suing Merck & Co. over allegations that the pharmaceutical ... He earned $326,056 in salary and benefits from the antivaccine group for three months of work in 2023 before taking ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best blue chip stocks to buy under $100. Blue chip stocks have long been considered the gold ...
Merck has announced the expansion of its Peenya facility in Bengaluru, positioning itself as a critical manufacturing hub for life science in the Asia-Pacific (APAC) region. This strategic development ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best depressed stocks to invest in now. The US stocks ended 2024 with a healthy Q4 ...
Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.
We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...
The Spanish CEO of the German giant: "I saw Sánchez in a closed-door meeting in Davos very much in line with Von der Leyen on ...